Comparison of second- and third-generation immunoassays for detection of anti-cyclic citrullinated peptide antibodies

References

• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581.
   PubMed Web of Science ®Google Scholar
• Taylor P, Gartemann J, Hsieh J, et al. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis. 2011;2011:1.
   Google Scholar
• Correia ML, Carvalho S, Fortuna J, et al. Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients. Clin Rev Allergy Immunol. 2008;34:21–25.
   PubMed Web of Science ®Google Scholar
• Silveira IG, Burlingame RW, von Mühlen CA, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol. 2007;26:1883–1889. − 
   PubMed Web of Science ®Google Scholar
• Didier K, Bolko L, Giusti D, et al. Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Front Immunol. 2018;9:541.
   PubMed Web of Science ®Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380–386.
   PubMed Web of Science ®Google Scholar
• Webb T, Lakos G, Swart A, et al. Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies. Clin Chim Acta. 2014;437:161–167.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tonutti E, Tozzoli R, et al. Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem. 2007;53:1527–1533.
   PubMed Web of Science ®Google Scholar
• Vos I, Van Mol C, Trouw LA, et al. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays. Clin Rheumatol. 2017;36:1487–1492.
   PubMed Web of Science ®Google Scholar
• Block DR, Jenkins SM, Dalenberg DA, et al. Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis. Clin Chim Acta. 2012;413:1015–1017.
   PubMed Web of Science ®Google Scholar
• Debaugnies F, Servais G, Badot V, et al. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis. Scand J Rheumatol. 2013;42:108–114.
   PubMed Web of Science ®Google Scholar
• Van Gaalen FA, Visser H, Huizinga TW. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1510–1512.
   PubMed Web of Science ®Google Scholar
• Santiago M, Baron M, Miyachi K, et al. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol. 2007;27:77–83.
   PubMed Web of Science ®Google Scholar
• Lutteri L, Malaise M, Chapelle JP. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clin Chim Acta. 2007;386:76–81.
   PubMed Web of Science ®Google Scholar
• Mutlu N, Bicakcigil M, Tasan DA, et al. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol. 2009;36:491–500.
   PubMed Web of Science ®Google Scholar
• Shidara K, Inoue E, Tanaka E, et al. Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int. 2011;31:617–622.
   PubMed Web of Science ®Google Scholar
• Harich R, Roger C, Garnier L, et al. Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort. Clin Biochem. 2014;47:485–488.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845.
   PubMed Web of Science ®Google Scholar
• Muller MP, Tomlinson G, Marrie TJ, et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?. Clin Infect Dis. 2005;40:1079–1086.
   PubMed Web of Science ®Google Scholar
• Hwang SM, Kim JO, Yoo YM, et al. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Clin Chem Lab Med. 2010;48:225–230.
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Song GG. Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis. Z Rheumatol. 2015;74:911–918.
   PubMed Web of Science ®Google Scholar
• Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2010;12:203
   PubMed Web of Science ®Google Scholar
• Rottmann M. Anti-CCP: challenges in quantifying auto-antibodies and creating international reference materials. Scand J Clin Lab Invest Suppl. 2010;242:44–45.
   PubMedGoogle Scholar
• Bizzaro N, Pregnolato F, van Boekel MA, et al. Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies. Ann Rheum Dis. 2012;71:1388–1392.
   PubMed Web of Science ®Google Scholar